- Home
- DDD vs FENC Comparison
DDD vs FENC Comparison
Compare DDD & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDD
- FENC
- Stock Information
- Founded
- DDD 1986
- FENC 1996
- Country
- DDD United States
- FENC United States
- Employees
- DDD N/A
- FENC N/A
- Industry
- DDD Computer peripheral equipment
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DDD Technology
- FENC Health Care
- Exchange
- DDD Nasdaq
- FENC Nasdaq
- Market Cap
- DDD 231.9M
- FENC 229.8M
- IPO Year
- DDD N/A
- FENC 2001
- Fundamental
- Price
- DDD $1.38
- FENC $7.76
- Analyst Decision
- DDD Hold
- FENC Strong Buy
- Analyst Count
- DDD 3
- FENC 2
- Target Price
- DDD $3.50
- FENC $13.00
- AVG Volume (30 Days)
- DDD 5.6M
- FENC 86.3K
- Earning Date
- DDD 05-12-2025
- FENC 08-12-2025
- Dividend Yield
- DDD N/A
- FENC N/A
- EPS Growth
- DDD N/A
- FENC N/A
- EPS
- DDD N/A
- FENC N/A
- Revenue
- DDD $431,756,000.00
- FENC $30,912,000.00
- Revenue This Year
- DDD N/A
- FENC $0.85
- Revenue Next Year
- DDD $3.55
- FENC $55.16
- P/E Ratio
- DDD N/A
- FENC N/A
- Revenue Growth
- DDD N/A
- FENC N/A
- 52 Week Low
- DDD $1.33
- FENC $3.96
- 52 Week High
- DDD $5.00
- FENC $8.72
- Technical
- Relative Strength Index (RSI)
- DDD 38.45
- FENC 51.69
- Support Level
- DDD $1.66
- FENC $7.53
- Resistance Level
- DDD $1.98
- FENC $8.19
- Average True Range (ATR)
- DDD 0.12
- FENC 0.47
- MACD
- DDD -0.01
- FENC -0.12
- Stochastic Oscillator
- DDD 1.30
- FENC 19.67
About DDD 3D Systems Corporation
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.